Heartflow (HTFL) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$212.1M

Revenue (quarter)

$64.1M

Revenue growth (year over year)

+47.57%

Gross profit (trailing twelve months)

$169.8M

Gross margin

80.08%

Net income (trailing twelve months)

−$118.4M

Net income (quarter)

−$15.7M

Net income growth (year over year)

−71.19%

Net margin

−55.82%

Return on equity

—

EPS (trailing twelve months)

$2.99

Book value per share

$3.23

P/E (trailing twelve months)

—

Price to book

15.37

Debt to assets

18.79%

Payout ratio

—

Dividend yield

—

Company profile

HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.

• Is Heartflow (HTFL) profitable?

  No. Heartflow reported a net loss of $118.4M over the trailing twelve months.

• How much revenue does Heartflow (HTFL) make?

  Heartflow generated $212.1M in revenue over the trailing twelve months, up 47.57% year over year.

• How do I buy stock in Heartflow (HTFL)?

  HTFL trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.